InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,352.96
(
-0.02%
)
US TECH 100
18,545.20
(
0.02%
)
Dow Jones
38,886.17
(
0.20%
)
Brent Oil
79.77
(
-0.14%
)
Bitcoin
70,746.76
(
-0.02%
)
Post# of 353142
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Pyckstocks

Send PM Follow Ignore
Followers 216
Posts 11783
Boards Moderated 3
Alias Born 01/20/2012

Pyckstocks

Re: None

Friday, 05/23/2014 9:07:01 AM

Friday, May 23, 2014 9:07:01 AM

Post# of 353142

$PPCH - Propanc Scientific have received queries regarding the anti-cancer effects and mechanism of action of proenzymes, which we published last year in collaboration with our research partners," said James Nathanielsz, Chief Executive Officer of Propanc Health Group, "Publishing these findings was an important step to gain credibility within the scientific community who recognize the potential of pancreatic proenzymes as a treatment for metastatic cancer." http://www.stockwatch.com/News/Item.aspx?bid=U-z10082871-U%3aPPCH-20140521&symbol=PPCH®ion=U

Come follow Super PYCKS for Super Players Board



All my posts are purely my opinion, Do your own dd please

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up